T1	Or 31 34	and
E1	Or:T1 Arg:T48 Arg2:T49
T2	Condition 46 59	premenopausal
E2	Condition:T2 Name:T51
T3	Observation 66 69	BMI
E3	Observation:T3 Name:T52 Eq-Comparison:E4
T4	Eq-Comparison 70 75	29-37
E4	Eq-Comparison:T4 Value:T53 Operator:T54
T5	Observation 81 87	Weight
E5	Observation:T5 Name:T56 Stability:T57
T6	Negation 100 103	Not
E6	Negation:T6 Negates:E7 Negates2:E26
T7	Condition 104 112	pregnant
E7	Condition:T7 Name:T58
T8	Or 112 113	/
E8	Or:T8 Arg:E7 Arg2:E26
T9	Condition 146 168	Ischemic heart disease
E9	Condition:T9 Name:T59
T10	Condition 174 206	Atherosclerotic valvular disease
E10	Condition:T10 Name:T60
T12	Eq-Comparison 221 244	>20 cigarettes per week
E12	Eq-Comparison:T12 Operator:T62 Value:T63 Unit:T64 Per:T65
T13	Procedure 261 273	oophorectomy
E13	Procedure:T13 Name:T67
T14	Modifier 279 290	Concomitant
E14	Modifier:T14 Modifies:E15
T15	Drug 298 309	medications
E15	Drug:T15 
T16	Assertion 315 318	can
E16	Assertion:T16 Asserted:T68
A1	Assertion-Type-Value E16 hypothetical
T17	Observation 325 344	serum lipid profile
E17	Observation:T17 Name:T69 Stability:T68
T18	Drug 366 374	fish oil
E18	Drug:T18 Name:T98 Dose:T70 Dose2:E19
T19	Eq-Comparison 376 387	>3g per day
E19	Eq-Comparison:T19 Operator:T71 Value:T72 Unit:T73 Per:T74
T20	Drug 400 407	STATINS
E20	Drug:T20 Name:T75
T21	Eq-Comparison 416 432	hold for 6 weeks
E21	Eq-Comparison:T21 Value:T76 Temporal-Unit:T77
T25	Drug 472 478	Niacin
E25	Drug:T25 Name:T79
T27	Drug 508 526	thiazolidinediones
E27	Drug:T27 Name:T81
T28	Drug 537 550	Beta-blockers
E28	Drug:T28 Name:T82
T29	Drug 570 584	antipsychotics
E29	Drug:T29 Name:T102
T30	Drug 590 599	Lidocaine
E30	Drug:T30 Name:T84
T31	Or 600 602	or
E31	Or:T31 Arg:E30 Arg2:E32
T32	Drug 603 609	Niacin
E32	Drug:T32 Name:T85
T33	Or 609 610	/
E33	Or:T33 Arg:E32 Arg2:E34
T34	Drug 610 617	Niaspan
E34	Drug:T34 Name:T86
T35	Allergy 618 625	allergy
E35	Allergy:T35 Name:E30 Name2:E32 Name3:E34
T36	Eq-Comparison 645 676	1.5 times upper limit of normal
E36	Eq-Comparison:T36 Value:T87 Unit:T88
T37	Observation 680 696	serum creatinine
E37	Observation:T37 Name:T89 Eq-Comparison:E36
T38	Observation 698 718	Alkaline phosphatase
E38	Observation:T38 Name:T90 Eq-Comparison:E36
T39	Observation 720 746	Aspartate aminotransferase
E39	Observation:T39 Name:T91 Eq-Comparison:E36
T40	Observation 748 751	AST
E40	Observation:T40 Name:T92
T41	Observation 754 778	Alanine aminotransferase
E41	Observation:T41 Name:T93 Eq-Comparison:E36
T42	Observation 780 783	ALT
E42	Observation:T42 Name:T94
T43	Exception 785 791	unless
E43	Exception:T43 From:E42 Except:E44 Except2:E45
T44	Condition 808 827	fatty liver disease
E44	Condition:T44 Name:T95
T45	Observation 829 844	Total bilirubin
E45	Observation:T45 Name:T96
T46	Exception 846 852	unless
E46	Exception:T46 From:E45 Except:E47
T47	Condition 880 898	Gilbert's syndrome
E47	Condition:T47 Name:T97
T48	Life-Stage-And-Gender 25 30	Women
A2	Life-Stage-And-Gender-Type T48 female
T49	Life-Stage-And-Gender 35 38	Men
A3	Life-Stage-And-Gender-Type T49 male
T50	Life-Stage-And-Gender 40 45	Women
A4	Life-Stage-And-Gender-Type T50 female
T51	Condition-Name 46 59	premenopausal
T52	Observation-Name 66 69	BMI
A5	Observation-Type-Value T52 vital
T53	Eq-Value 70 72	29
T54	Eq-Operator 72 73	-
A6	Eq-Operator-Value T54 BETWEEN
T55	Eq-Value 73 75	37
T56	Observation-Name 81 87	Weight
A7	Observation-Type-Value T56 vital
T57	Stability 88 94	stable
A8	Stability-Value T57 stable
T58	Condition-Name 104 112	pregnant
T59	Condition-Name 146 168	Ischemic heart disease
T60	Condition-Name 174 206	Atherosclerotic valvular disease
T62	Eq-Operator 221 222	>
A9	Eq-Operator-Value T62 GT
T63	Eq-Value 222 224	20
T64	Eq-Unit 225 235	cigarettes
T65	Eq-Temporal-Unit 240 244	week
A10	Eq-Temporal-Unit-Value T65 week
T67	Procedure-Name 261 273	oophorectomy
T68	Stability 319 324	alter
A12	Stability-Value T68 change
T69	Observation-Name 325 344	serum lipid profile
A13	Observation-Type-Value T69 lab
T70	Polarity 356 360	High
A14	Polarity-Value T70 high
T71	Eq-Operator 376 377	>
A15	Eq-Operator-Value T71 GT
T72	Eq-Value 377 378	3
T73	Eq-Unit 378 379	g
T74	Eq-Temporal-Unit 384 387	day
A16	Eq-Temporal-Unit-Value T74 day
T75	Drug-Name 400 407	STATINS
T76	Eq-Value 425 426	6
T77	Eq-Temporal-Unit 427 432	weeks
A17	Eq-Temporal-Unit-Value T77 week
T79	Drug-Name 472 478	Niacin
T81	Drug-Name 508 526	thiazolidinediones
T82	Drug-Name 537 550	Beta-blockers
T84	Drug-Name 590 599	Lidocaine
T85	Drug-Name 603 609	Niacin
T86	Drug-Name 610 617	Niaspan
T87	Eq-Value 645 648	1.5
T88	Eq-Unit 655 676	upper limit of normal
A18	Eq-Unit-Value T88 ref-range-normal
T89	Observation-Name 680 696	serum creatinine
A19	Observation-Type-Value T89 lab
T90	Observation-Name 698 718	Alkaline phosphatase
A20	Observation-Type-Value T90 lab
T91	Observation-Name 720 746	Aspartate aminotransferase
A21	Observation-Type-Value T91 lab
T92	Observation-Name 748 751	AST
A22	Observation-Type-Value T92 lab
T93	Observation-Name 754 778	Alanine aminotransferase
A23	Observation-Type-Value T93 lab
T94	Observation-Name 780 783	ALT
A24	Observation-Type-Value T94 lab
T95	Condition-Name 808 827	fatty liver disease
T96	Observation-Name 829 844	Total bilirubin
A25	Observation-Type-Value T96 lab
T97	Condition-Name 880 898	Gilbert's syndrome
R1	If-Then Arg1:T50 Arg2:E2	
T26	Condition 113 120	nursing
E26	Condition:T26 Name:T80
T80	Condition-Name 113 120	nursing
T83	Observation 212 219	Smokers
E48	Observation:T83 Eq-Comparison:E12 Name:T11
T66	Modifier 251 260	Bilateral
E49	Modifier:T66 Modifies:T67
R2	Caused-By Arg1:T68 Arg2:E15	
T98	Drug-Name 366 374	fish oil
R3	Equivalent-To Arg1:E19 Arg2:T70	
T22	Drug 489 497	Fibrates
E22	Drug:T22 Name:T23
T23	Drug-Name 489 497	Fibrates
T24	Provider 445 448	PCP
E23	Provider:T24 Role:T78
T78	Provider-Role 445 448	PCP
T99	Observation 451 459	approval
E24	Observation:T99 Name:T100 Provider:E23
T100	Observation-Name 451 459	approval
T101	Modifier 561 569	Atypical
E50	Modifier:T101 Modifies:T102
T102	Drug-Name 570 584	antipsychotics
R4	Abbrev-Of Arg1:E40 Arg2:E39	
R5	Abbrev-Of Arg1:E42 Arg2:E41	
T11	Observation-Name 212 219	Smokers
A11	Observation-Type-Value T11 social-habit
